|
|
||||||||
Radiology, Vol 205, 27-36, Copyright © 1997 by Radiological Society of North America
ARTICLES |
WF Pritchard Jr and RF Carey
Office of Science and Technology, U.S. Food and Drug Administration (HFZ-132), Rockville, MD 20852, USA.
The recent decision by the U.S. Food and Drug Administration (FDA) to approve one ultrasound imaging system for use in making breast biopsy decisions prompted considerable interest in the radiology community about the regulatory process and the associated implications for the practice of medicine. In this report, the concepts and statutory authority guiding the FDA in the regulation of medical devices are summarized and discussed, including the device classification scheme, premarket approval, premarket notification, and investigational device exemptions. Also, the critical concepts of safety and effectiveness for a given indication for use, the roles of advisory panels, and examples of imaging and interventional devices are described to shed light on the approval process.
This article has been cited by other articles:
![]() |
M. E. Matheny, L. Ohno-Machado, and F. S. Resnic Monitoring Device Safety in Interventional Cardiology J. Am. Med. Inform. Assoc., March 1, 2006; 13(2): 180 - 187. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. H. Maisel Safety Issues Involving Medical Devices: Implications of Recent Implantable Cardioverter-Defibrillator Malfunctions JAMA, August 24, 2005; 294(8): 955 - 958. [Full Text] [PDF] |
||||
![]() |
W. H. Maisel Medical Device Regulation: An Introduction for the Practicing Physician Ann Intern Med, February 17, 2004; 140(4): 296 - 302. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Smith Regulation of Medical Devices in Radiology: Current Standards and Future Opportunities Radiology, February 1, 2001; 218(2): 329 - 335. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |